Life sciences industry is changing drug development with AI [Video]

While much of what is being said about artificial intelligence can feel like enterprise buzzwords, applications with real-world impact are also on the horizon, especially in the life sciences and healthcare.

“Our motto at Insmed is: The patient is our North Star,” said Chris Colucci (pictured left), vice president of information technology at Insmed Inc., a company focused on developing and commercializing therapies for patients with rare diseases. “If you think about the past two years, how generative AI has taken us by storm, we started to look internally and say, how can we adapt our business process to help accelerate the drug development process, the discovery and eventually get product to patients?” 

Colucci and Saurabh Mishra (pictured right), global leader of the Google Cloud business at Quantiphi Inc., spoke with theCUBE Research analysts Savannah Peterson and Rob Strechay at Google Cloud Next 2024, during an exclusive broadcast on theCUBE, SiliconANGLE …